Vascular Closure Devices Market Research Report Information By Product Type (Passive Vascular Closure Device, Active Vascular Closure Device, and External Hemostatic Device), By Access (Femoral and Radial), By Procedures (Interventional Cardiology and Interventional Radiology), By Application (Diagnostic and Therapeutic), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032

Table Of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Overview

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

Chapter 6. Global Vascular Closure Devices Market, By Product Type

6.1 Overview

6.2 Passive Vascular Closure Devices

6.2.1 Plug-Based Devices

6.2.2 Sealant Or Gel-Based Devices

6.2.3 Compression Assist Devices

6.3 Active Vascular Closure Devices

6.3.1 Clip-Based Devices

6.3.2 Suture-Based Devices

6.3.3 Gamma-Retroviral Vectors

6.4 External Hemostatic Devices

Chapter 7. Global Vascular Closure Devices Market, By Access

7.1 Overview

7.2 Femoral Access

7.3 Radial Access

Chapter 8. Global Vascular Closure Devices Market, By Procedures

8.1 Overview

8.2 Interventional Cardiology

8.3 Interventional Radiology/Vascular Surgery

Chapter 9. Global Vascular Closure Devices Market, By Application

9.1 Overview

9.2 Diagnostic Intervention

9.3 Therapeutic Intervention

Chapter 10. Global Vascular Closure Devices Market, By End User

10.1 Introduction

10.2 Hospitals & Clinics

10.3 Specialty Centers

10.4 Ambulatory Surgery Centers

10.5 Others

Chapter 11. Global Vascular Closure Devices Market, By Region

11.1 Introduction

11.2 Americas

11.2.1 North America

11.2.1.1 US

11.2.1.2 Canada

11.2.2 Latin America

11.3 Europe

11.3.1 Western Europe

11.3.1.1 Germany

11.3.1.2 France

11.3.1.3 Italy

11.3.1.4 Spain

11.3.1.5 UK

11.3.1.6 Rest Of Western Europe

11.3.2 Eastern Europe

11.4 Asia-Pacific

11.4.1 Japan

11.4.2 China

11.4.3 India

11.4.4 Australia

11.4.5 South Korea

11.4.6 Rest Of Asia-Pacific

11.5 Middle East & Africa

11.5.1 Middle East

11.5.2 Africa

Chapter 12. Company Landscape

12.1 Introduction

12.2 Market Share Analysis

Chapter 13. Company Profiles

13.1 Abbott Laboratories

13.1.1 Company Overview

13.1.2 Product Overview

13.1.3 Financials Overview

13.1.4 Key Developments

13.1.5 SWOT Analysis

13.2 Terumo Corporation

13.3 Cardinal Health Inc.

13.4 Cardiva Medical Inc.

13.5 Morris Innovative, Inc.

13.6 Medtronic Plc

13.7 Essential Medical, Inc.

13.8 Merit Medical Systems, Inc.

13.9 TZ Medical, Inc.

13.10 Vasorum Ltd.

13.13 Transluminal Technologies LLC

13.12 Vascular Closure Systems, Inc.

13.13 Vivasure Medical Ltd.

13.14 Others

Chapter 14 Appendix

LIST OF TABLES

TABLE 1 GLOBAL VASCULAR CLOSURE DEVICES MARKET SYNOPSIS, 2020–2027

TABLE 2 GLOBAL VASCULAR CLOSURE DEVICES MARKET ESTIMATES AND FORECAST, 2020–2027 (USD MILLION)

TABLE 3 GLOBAL VASCULAR CLOSURE DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 4 GLOBAL VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2020–2027 (USD MILLION)

TABLE 5 GLOBAL VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2020–2027 (USD MILLION)

TABLE 6 GLOBAL VASCULAR CLOSURE DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 7 GLOBAL VASCULAR CLOSURE DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 8 GLOBAL VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2020–2027(USD MILLION)

TABLE 9 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 10 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2020–2027 (USD MILLION)

TABLE 11 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2020–2027 (USD MILLION)

TABLE 12 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 13 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 14 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)

TABLE 15 US: VASCULAR CLOSURE DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 16 US: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2020–2027 (USD MILLION)

TABLE 17 US: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2020–2027 (USD MILLION)

TABLE 18 US: VASCULAR CLOSURE DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 19 US: VASCULAR CLOSURE DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 20 US: VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)

TABLE 21 CANADA: VASCULAR CLOSURE DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 22 CANADA: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2020–2027 (USD MILLION)

TABLE 23 CANADA: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2020–2027 (USD MILLION)

TABLE 24 CANADA: VASCULAR CLOSURE DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 25 CANADA: VASCULAR CLOSURE DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 26 CANADA: VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)

TABLE 27 SOUTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 28 SOUTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2020–2027 (USD MILLION)

TABLE 29 SOUTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2020–2027 (USD MILLION)

TABLE 30 SOUTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 31 SOUTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 32 SOUTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)

TABLE 33 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 34 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2020–2027 (USD MILLION)

TABLE 35 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2020–2027 (USD MILLION)

TABLE 36 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 37 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 38 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)

TABLE 39 WESTERN EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 40 WESTERN EUROPE VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2020–2027 (USD MILLION)

TABLE 41 WESTERN EUROPE VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2020–2027 (USD MILLION)

TABLE 42 WESTERN EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 43 WESTERN EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 44 WESTERN EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)

TABLE 45 EASTERN EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 46 EASTERN EUROPE VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2020–2027 (USD MILLION)

TABLE 47 EASTERN EUROPE VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2020–2027 (USD MILLION)

TABLE 48 EASTERN EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 49 EASTERN EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 50 EASTERN EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)

TABLE 51 ASIA-PACIFIC: VASCULAR CLOSURE DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 52 ASIA-PACIFIC VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2020–2027 (USD MILLION)

TABLE 53 ASIA-PACIFIC VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2020–2027 (USD MILLION)

TABLE 54 ASIA-PACIFIC: VASCULAR CLOSURE DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 55 ASIA-PACIFIC: VASCULAR CLOSURE DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 56 ASIA-PACIFIC: VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)

TABLE 57 MIDDLE EAST & AFRICA: VASCULAR CLOSURE DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 58 MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2020–2027 (USD MILLION)

TABLE 59 MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2020–2027 (USD MILLION)

TABLE 60 MIDDLE EAST & AFRICA: VASCULAR CLOSURE DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 61 MIDDLE EAST & AFRICA: VASCULAR CLOSURE DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 62 MIDDLE EAST & AFRICA: VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 SEGMENTATION FOR GLOBAL VASCULAR CLOSURE DEVICES MARKET

FIGURE 3 MARKET DYNAMICS FOR GLOBAL VASCULAR CLOSURE DEVICES MARKET

FIGURE 4 GLOBAL VASCULAR CLOSURE DEVICES MARKET SHARE, BY PRODUCT TYPE, 2020 (%)

FIGURE 5 GLOBAL VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2020 (%)

FIGURE 6 GLOBAL VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2020 (%)

FIGURE 7 GLOBAL VASCULAR CLOSURE DEVICES MARKET SHARE, BY APPLICATION, 2020 (%)

FIGURE 8 GLOBAL VASCULAR CLOSURE DEVICES MARKET SHARE, BY END USER, 2020 (%)

FIGURE 9 GLOBAL VASCULAR CLOSURE DEVICES MARKET SHARE, BY REGION, 2020 (%)

FIGURE 10 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 11 EUROPE: VASCULAR CLOSURE DEVICES MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 12 ASIA-PACIFIC: VASCULAR CLOSURE DEVICES MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 13 MIDDLE EAST & AFRICA: VASCULAR CLOSURE DEVICES MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 14 GLOBAL VASCULAR CLOSURE DEVICES MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

FIGURE 15 ABBOTT LABORATORIES: KEY FINANCIALS

FIGURE 16 ABBOTT LABORATORIES: SEGMENTAL REVENUE

FIGURE 17 ABBOTT LABORATORIES: GEOGRAPHICAL REVENUE

FIGURE 18 TERUMO CORPORATION: KEY FINANCIALS

FIGURE 19 TERUMO CORPORATION: SEGMENTAL REVENUE

FIGURE 20 TERUMO CORPORATION: GEOGRAPHICAL REVENUE

FIGURE 21 CARDIVA MEDICAL INC: KEY FINANCIALS

FIGURE 22 CARDIVA MEDICAL INC: SEGMENTAL REVENUE

FIGURE 23 CARDIVA MEDICAL INC: GEOGRAPHICAL REVENUE

FIGURE 24 MEDTRONIC PLC: KEY FINANCIALS

FIGURE 25 MEDTRONIC PLC: SEGMENTAL REVENUE

FIGURE 26 MEDTRONIC PLC: GEOGRAPHICAL REVENUE

FIGURE 27 VASORUM LTD: KEY FINANCIALS

FIGURE 28 VASORUM LTD: SEGMENTAL REVENUE

FIGURE 29 VASORUM LTD: GEOGRAPHICAL REVENUE

FIGURE 30 TZ MEDICAL, INC: KEY FINANCIALS

FIGURE 31 TZ MEDICAL, INC: SEGMENTAL REVENUE

FIGURE 32 TZ MEDICAL, INC: GEOGRAPHICAL REVENUE

FIGURE 33 VASCULAR CLOSURE SYSTEMS, INC: KEY FINANCIALS

FIGURE 34 VASCULAR CLOSURE SYSTEMS, INC: SEGMENTAL REVENUE

FIGURE 35 VASCULAR CLOSURE SYSTEMS, INC: GEOGRAPHICAL REVENUE

FIGURE 36 CARDINAL HEALTH: KEY FINANCIALS

FIGURE 37 CARDINAL HEALTH: SEGMENTAL REVENUE

FIGURE 38 CARDINAL HEALTH: GEOGRAPHICAL REVENUE

FIGURE 39 VIVASURE MEDICAL LTD: KEY FINANCIALS

FIGURE 40 VIVASURE MEDICAL LTD: SEGMENTAL REVENUE

FIGURE 41 VIVASURE MEDICAL LTD: GEOGRAPHICAL REVENUE

FIGURE 42 ESSENTIAL MEDICAL, INC.: KEY FINANCIALS

FIGURE 43 ESSENTIAL MEDICAL, INC.: SEGMENTAL REVENUE

FIGURE 44 ESSENTIAL MEDICAL, INC.: GEOGRAPHICAL REVENUE